 | • レポートコード：MRC2Q12-19459 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、注射用ビンポセチンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 注射用ビンポセチンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ビンポセチンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 注射用ビンポセチンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの注射用ビンポセチンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の注射用ビンポセチンの売上および2028年までの予測に焦点を当てています。 注射用ビンポセチンのグローバル主要企業には、Shanxi PUDE Pharmaceutical、Hunan Wuzhoutong Pharmaceutical、Harbin Medisan Pharmaceutical、Reyoung Pharmaceutical、Hebei Zhitong Biopharmaceutical、Fujian Mindong Rejuenation Pharmaceutical、Guangzhou Invin Pharmaceutical、Anhui Weiman Pharmaceutical、Changchun HaiYue Pharmaceutical、Yunnan Mengsheng Pharmceutical、Changchun Haiwang Biological Pharmaceutical、Dezhou Deyao Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 注射用ビンポセチン市場は、タイプとアプリケーションによって区分されます。世界の注射用ビンポセチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 10mg/ボトル（ビンポセチン換算）、20mg/ボトル（ビンポセチン換算）、30mg/ボトル（ビンポセチン換算） 【アプリケーション別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 注射用ビンポセチン製品概要 - タイプ別市場（10mg/ボトル（ビンポセチン換算）、20mg/ボトル（ビンポセチン換算）、30mg/ボトル（ビンポセチン換算）） - アプリケーション別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の注射用ビンポセチン販売量予測2017-2028 - 世界の注射用ビンポセチン売上予測2017-2028 - 注射用ビンポセチンの地域別販売量 - 注射用ビンポセチンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別注射用ビンポセチン販売量 - 主要メーカー別注射用ビンポセチン売上 - 主要メーカー別注射用ビンポセチン価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（10mg/ボトル（ビンポセチン換算）、20mg/ボトル（ビンポセチン換算）、30mg/ボトル（ビンポセチン換算）） - 注射用ビンポセチンのタイプ別販売量 - 注射用ビンポセチンのタイプ別売上 - 注射用ビンポセチンのタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店薬局、その他） - 注射用ビンポセチンのアプリケーション別販売量 - 注射用ビンポセチンのアプリケーション別売上 - 注射用ビンポセチンのアプリケーション別価格 ・北米市場 - 北米の注射用ビンポセチン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ビンポセチン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの注射用ビンポセチン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ビンポセチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の注射用ビンポセチン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ビンポセチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の注射用ビンポセチン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ビンポセチン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの注射用ビンポセチン市場規模（タイプ別、アプリケーション別） - 主要国別の注射用ビンポセチン市場規模（トルコ、サウジアラビア） ・企業情報 Shanxi PUDE Pharmaceutical、Hunan Wuzhoutong Pharmaceutical、Harbin Medisan Pharmaceutical、Reyoung Pharmaceutical、Hebei Zhitong Biopharmaceutical、Fujian Mindong Rejuenation Pharmaceutical、Guangzhou Invin Pharmaceutical、Anhui Weiman Pharmaceutical、Changchun HaiYue Pharmaceutical、Yunnan Mengsheng Pharmceutical、Changchun Haiwang Biological Pharmaceutical、Dezhou Deyao Pharmaceutical ・産業チェーン及び販売チャネル分析 - 注射用ビンポセチンの産業チェーン分析 - 注射用ビンポセチンの原材料 - 注射用ビンポセチンの生産プロセス - 注射用ビンポセチンの販売及びマーケティング - 注射用ビンポセチンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 注射用ビンポセチンの産業動向 - 注射用ビンポセチンのマーケットドライバー - 注射用ビンポセチンの課題 - 注射用ビンポセチンの阻害要因 ・主な調査結果 |
Market Analysis and Insights: Global Vinpocetine for Injection Market
Due to the COVID-19 pandemic, the global Vinpocetine for Injection market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 10mg/Bottle (Calculated As Vinpocetine) accounting for % of the Vinpocetine for Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Vinpocetine for Injection market size is valued at US$ million in 2021, while the US and Europe Vinpocetine for Injection are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vinpocetine for Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Vinpocetine for Injection include Shanxi PUDE Pharmaceutical, Hunan Wuzhoutong Pharmaceutical, Harbin Medisan Pharmaceutical, Reyoung Pharmaceutical, Hebei Zhitong Biopharmaceutical, Fujian Mindong Rejuenation Pharmaceutical, Guangzhou Invin Pharmaceutical, Anhui Weiman Pharmaceutical and Changchun HaiYue Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Vinpocetine for Injection Scope and Segment
Vinpocetine for Injection market is segmented by Specification and by Application. Players, stakeholders, and other participants in the global Vinpocetine for Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Specification and by Application for the period 2017-2028.
Segment by Specification
10mg/Bottle (Calculated As Vinpocetine)
20mg/Bottle (Calculated As Vinpocetine)
30mg/Bottle (Calculated As Vinpocetine)
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others
By Company
Shanxi PUDE Pharmaceutical
Hunan Wuzhoutong Pharmaceutical
Harbin Medisan Pharmaceutical
Reyoung Pharmaceutical
Hebei Zhitong Biopharmaceutical
Fujian Mindong Rejuenation Pharmaceutical
Guangzhou Invin Pharmaceutical
Anhui Weiman Pharmaceutical
Changchun HaiYue Pharmaceutical
Yunnan Mengsheng Pharmceutical
Changchun Haiwang Biological Pharmaceutical
Dezhou Deyao Pharmaceutical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Vinpocetine for Injection Product Introduction
1.2 Market by Specification
1.2.1 Global Vinpocetine for Injection Market Size Growth Rate by Specification, 2017 VS 2021 VS 2028
1.2.2 10mg/Bottle (Calculated As Vinpocetine)
1.2.3 20mg/Bottle (Calculated As Vinpocetine)
1.2.4 30mg/Bottle (Calculated As Vinpocetine)
1.3 Market by Application
1.3.1 Global Vinpocetine for Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vinpocetine for Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Vinpocetine for Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Vinpocetine for Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vinpocetine for Injection Sales by Region
2.4.1 Global Vinpocetine for Injection Sales by Region (2017-2022)
2.4.2 Global Sales Vinpocetine for Injection by Region (2023-2028)
2.5 Global Vinpocetine for Injection Revenue by Region
2.5.1 Global Vinpocetine for Injection Revenue by Region (2017-2022)
2.5.2 Global Vinpocetine for Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vinpocetine for Injection Sales by Manufacturers
3.1.1 Global Top Vinpocetine for Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Vinpocetine for Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vinpocetine for Injection in 2021
3.2 Global Vinpocetine for Injection Revenue by Manufacturers
3.2.1 Global Vinpocetine for Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Vinpocetine for Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vinpocetine for Injection Revenue in 2021
3.3 Global Vinpocetine for Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vinpocetine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vinpocetine for Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Specification
4.1 Global Vinpocetine for Injection Sales by Specification
4.1.1 Global Vinpocetine for Injection Historical Sales by Specification (2017-2022)
4.1.2 Global Vinpocetine for Injection Forecasted Sales by Specification (2023-2028)
4.1.3 Global Vinpocetine for Injection Sales Market Share by Specification (2017-2028)
4.2 Global Vinpocetine for Injection Revenue by Specification
4.2.1 Global Vinpocetine for Injection Historical Revenue by Specification (2017-2022)
4.2.2 Global Vinpocetine for Injection Forecasted Revenue by Specification (2023-2028)
4.2.3 Global Vinpocetine for Injection Revenue Market Share by Specification (2017-2028)
4.3 Global Vinpocetine for Injection Price by Specification
4.3.1 Global Vinpocetine for Injection Price by Specification (2017-2022)
4.3.2 Global Vinpocetine for Injection Price Forecast by Specification (2023-2028)
5 Market Size by Application
5.1 Global Vinpocetine for Injection Sales by Application
5.1.1 Global Vinpocetine for Injection Historical Sales by Application (2017-2022)
5.1.2 Global Vinpocetine for Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Vinpocetine for Injection Sales Market Share by Application (2017-2028)
5.2 Global Vinpocetine for Injection Revenue by Application
5.2.1 Global Vinpocetine for Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Vinpocetine for Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vinpocetine for Injection Revenue Market Share by Application (2017-2028)
5.3 Global Vinpocetine for Injection Price by Application
5.3.1 Global Vinpocetine for Injection Price by Application (2017-2022)
5.3.2 Global Vinpocetine for Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vinpocetine for Injection Market Size by Specification
6.1.1 North America Vinpocetine for Injection Sales by Specification (2017-2028)
6.1.2 North America Vinpocetine for Injection Revenue by Specification (2017-2028)
6.2 North America Vinpocetine for Injection Market Size by Application
6.2.1 North America Vinpocetine for Injection Sales by Application (2017-2028)
6.2.2 North America Vinpocetine for Injection Revenue by Application (2017-2028)
6.3 North America Vinpocetine for Injection Market Size by Country
6.3.1 North America Vinpocetine for Injection Sales by Country (2017-2028)
6.3.2 North America Vinpocetine for Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vinpocetine for Injection Market Size by Specification
7.1.1 Europe Vinpocetine for Injection Sales by Specification (2017-2028)
7.1.2 Europe Vinpocetine for Injection Revenue by Specification (2017-2028)
7.2 Europe Vinpocetine for Injection Market Size by Application
7.2.1 Europe Vinpocetine for Injection Sales by Application (2017-2028)
7.2.2 Europe Vinpocetine for Injection Revenue by Application (2017-2028)
7.3 Europe Vinpocetine for Injection Market Size by Country
7.3.1 Europe Vinpocetine for Injection Sales by Country (2017-2028)
7.3.2 Europe Vinpocetine for Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vinpocetine for Injection Market Size by Specification
8.1.1 Asia Pacific Vinpocetine for Injection Sales by Specification (2017-2028)
8.1.2 Asia Pacific Vinpocetine for Injection Revenue by Specification (2017-2028)
8.2 Asia Pacific Vinpocetine for Injection Market Size by Application
8.2.1 Asia Pacific Vinpocetine for Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Vinpocetine for Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Vinpocetine for Injection Market Size by Region
8.3.1 Asia Pacific Vinpocetine for Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Vinpocetine for Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vinpocetine for Injection Market Size by Specification
9.1.1 Latin America Vinpocetine for Injection Sales by Specification (2017-2028)
9.1.2 Latin America Vinpocetine for Injection Revenue by Specification (2017-2028)
9.2 Latin America Vinpocetine for Injection Market Size by Application
9.2.1 Latin America Vinpocetine for Injection Sales by Application (2017-2028)
9.2.2 Latin America Vinpocetine for Injection Revenue by Application (2017-2028)
9.3 Latin America Vinpocetine for Injection Market Size by Country
9.3.1 Latin America Vinpocetine for Injection Sales by Country (2017-2028)
9.3.2 Latin America Vinpocetine for Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Vinpocetine for Injection Market Size by Specification
10.1.1 Middle East and Africa Vinpocetine for Injection Sales by Specification (2017-2028)
10.1.2 Middle East and Africa Vinpocetine for Injection Revenue by Specification (2017-2028)
10.2 Middle East and Africa Vinpocetine for Injection Market Size by Application
10.2.1 Middle East and Africa Vinpocetine for Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vinpocetine for Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Vinpocetine for Injection Market Size by Country
10.3.1 Middle East and Africa Vinpocetine for Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vinpocetine for Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Shanxi PUDE Pharmaceutical
11.1.1 Shanxi PUDE Pharmaceutical Corporation Information
11.1.2 Shanxi PUDE Pharmaceutical Overview
11.1.3 Shanxi PUDE Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Shanxi PUDE Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Shanxi PUDE Pharmaceutical Recent Developments
11.2 Hunan Wuzhoutong Pharmaceutical
11.2.1 Hunan Wuzhoutong Pharmaceutical Corporation Information
11.2.2 Hunan Wuzhoutong Pharmaceutical Overview
11.2.3 Hunan Wuzhoutong Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Hunan Wuzhoutong Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Hunan Wuzhoutong Pharmaceutical Recent Developments
11.3 Harbin Medisan Pharmaceutical
11.3.1 Harbin Medisan Pharmaceutical Corporation Information
11.3.2 Harbin Medisan Pharmaceutical Overview
11.3.3 Harbin Medisan Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Harbin Medisan Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Harbin Medisan Pharmaceutical Recent Developments
11.4 Reyoung Pharmaceutical
11.4.1 Reyoung Pharmaceutical Corporation Information
11.4.2 Reyoung Pharmaceutical Overview
11.4.3 Reyoung Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Reyoung Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Reyoung Pharmaceutical Recent Developments
11.5 Hebei Zhitong Biopharmaceutical
11.5.1 Hebei Zhitong Biopharmaceutical Corporation Information
11.5.2 Hebei Zhitong Biopharmaceutical Overview
11.5.3 Hebei Zhitong Biopharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Hebei Zhitong Biopharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Hebei Zhitong Biopharmaceutical Recent Developments
11.6 Fujian Mindong Rejuenation Pharmaceutical
11.6.1 Fujian Mindong Rejuenation Pharmaceutical Corporation Information
11.6.2 Fujian Mindong Rejuenation Pharmaceutical Overview
11.6.3 Fujian Mindong Rejuenation Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Fujian Mindong Rejuenation Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Fujian Mindong Rejuenation Pharmaceutical Recent Developments
11.7 Guangzhou Invin Pharmaceutical
11.7.1 Guangzhou Invin Pharmaceutical Corporation Information
11.7.2 Guangzhou Invin Pharmaceutical Overview
11.7.3 Guangzhou Invin Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Guangzhou Invin Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Guangzhou Invin Pharmaceutical Recent Developments
11.8 Anhui Weiman Pharmaceutical
11.8.1 Anhui Weiman Pharmaceutical Corporation Information
11.8.2 Anhui Weiman Pharmaceutical Overview
11.8.3 Anhui Weiman Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Anhui Weiman Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Anhui Weiman Pharmaceutical Recent Developments
11.9 Changchun HaiYue Pharmaceutical
11.9.1 Changchun HaiYue Pharmaceutical Corporation Information
11.9.2 Changchun HaiYue Pharmaceutical Overview
11.9.3 Changchun HaiYue Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Changchun HaiYue Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Changchun HaiYue Pharmaceutical Recent Developments
11.10 Yunnan Mengsheng Pharmceutical
11.10.1 Yunnan Mengsheng Pharmceutical Corporation Information
11.10.2 Yunnan Mengsheng Pharmceutical Overview
11.10.3 Yunnan Mengsheng Pharmceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Yunnan Mengsheng Pharmceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Yunnan Mengsheng Pharmceutical Recent Developments
11.11 Changchun Haiwang Biological Pharmaceutical
11.11.1 Changchun Haiwang Biological Pharmaceutical Corporation Information
11.11.2 Changchun Haiwang Biological Pharmaceutical Overview
11.11.3 Changchun Haiwang Biological Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Changchun Haiwang Biological Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Changchun Haiwang Biological Pharmaceutical Recent Developments
11.12 Dezhou Deyao Pharmaceutical
11.12.1 Dezhou Deyao Pharmaceutical Corporation Information
11.12.2 Dezhou Deyao Pharmaceutical Overview
11.12.3 Dezhou Deyao Pharmaceutical Vinpocetine for Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Dezhou Deyao Pharmaceutical Vinpocetine for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Dezhou Deyao Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vinpocetine for Injection Industry Chain Analysis
12.2 Vinpocetine for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vinpocetine for Injection Production Mode & Process
12.4 Vinpocetine for Injection Sales and Marketing
12.4.1 Vinpocetine for Injection Sales Channels
12.4.2 Vinpocetine for Injection Distributors
12.5 Vinpocetine for Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vinpocetine for Injection Industry Trends
13.2 Vinpocetine for Injection Market Drivers
13.3 Vinpocetine for Injection Market Challenges
13.4 Vinpocetine for Injection Market Restraints
14 Key Findings in The Global Vinpocetine for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer